A nested case-control study on treatment-related risk factors for early relapse of tuberculosis
Publication in refereed journal

Times Cited
Web of Science104WOS source URL (as at 20/09/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractThis nested case-control study aimed at evaluating treatment-related risk factors of relapse of tuberculosis under a service program of directly observed treatment. Out of 12,183 patients with pulmonary tuberculosis who completed treatment within I year, 113 relapsed within 30 months after commencement of therapy. The overall 30-month relapse rate was 0.9% (95% confidence interval [CI] 0.8-1.1%). On matching 113 cases with 226 control subjects in a conditional logistic model, thrice-weekly treatment increased the risk of relapse in comparison with daily treatment (odds ratio 3.92, 95% CI 1.78-8.63), whereas prolonging both intensive phase and overall treatment by 50% or more protected against relapse (odds ratio 0.24, 95% CI 0.08-0.70). When pretreatment culture was positive and cavitation was absent, the 30-month relapse rate for standard thrice-weekly regimen was 1.1% (95% CI 0.6-2.0%). The corresponding rates in the presence of cavitation were 7.8% (95% CI 4.0-14.6%) for standard thrice-weekly regimen; 3.3% (95% CI 1.9-5.5%) for standard daily regimen; 0.5% (95% CI 0.1-2.6%) for extended thrice-weekly regimen; and 0.4% (95% CI 0.1-0.9%) for extended daily regimen. Further studies are required to reduce the risk of relapse under program settings.
All Author(s) ListChang KC, Leung CC, Yew WW, Ho SC, Tam CM
Journal nameAmerican Journal of Respiratory and Critical Care Medicine
Volume Number170
Issue Number10
Pages1124 - 1130
LanguagesEnglish-United Kingdom
Keywordslogistic models; recurrence; risk factors; therapeutics; tuberculosis
Web of Science Subject CategoriesCritical Care Medicine; CRITICAL CARE MEDICINE; General & Internal Medicine; Respiratory System; RESPIRATORY SYSTEM

Last updated on 2021-21-09 at 00:23